APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,303,033 | +0.4% | 191,983 | +140.6% | 0.02% | -26.9% |
| Q2 2023 | $7,270,600 | -13.7% | 79,809 | -37.5% | 0.03% | -79.4% |
| Q1 2023 | $8,428,237 | +494.9% | 127,778 | +366.3% | 0.13% | +384.6% |
| Q4 2022 | $1,416,854 | +29.6% | 27,400 | +71.2% | 0.03% | +23.8% |
| Q3 2022 | $1,093,000 | +69.5% | 16,000 | +26.1% | 0.02% | +23.5% |
| Q1 2022 | $645,000 | -88.1% | 12,687 | -89.0% | 0.02% | -89.9% |
| Q4 2021 | $5,443,000 | +742.6% | 115,133 | +377.7% | 0.17% | +19.0% |
| Q1 2020 | $646,000 | – | 24,100 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |